This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Oct;25(12):1686-1687.

doi: 10.1177/1352458519872897. Epub 2019 Aug 22.

PML with dimethyl fumarate-No role for natalizumab?

Joseph R Berger¹

Affiliations

PMID: 31436127
DOI: 10.1177/1352458519872897

Comment

PML with dimethyl fumarate-No role for natalizumab?

Joseph R Berger. Mult Scler. 2019 Oct.

. 2019 Oct;25(12):1686-1687.

doi: 10.1177/1352458519872897. Epub 2019 Aug 22.

Author

Joseph R Berger¹

Affiliation

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

PMID: 31436127
DOI: 10.1177/1352458519872897

No abstract available

PubMed Disclaimer

Comment in

PML with dimethyl fumarate-No convincing case against natalizumab.
Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J. Diebold M, et al. Mult Scler. 2019 Oct;25(12):1687-1688. doi: 10.1177/1352458519872894. Epub 2019 Aug 22. Mult Scler. 2019. PMID: 31436113 No abstract available.

Comment on

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence.
Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J. Diebold M, et al. Mult Scler. 2019 Oct;25(12):1682-1685. doi: 10.1177/1352458519852100. Epub 2019 Jun 18. Mult Scler. 2019. PMID: 31208265

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information